# FDA 483 - Aurobindo Pharma USA Inc - May 15, 2024

Source: https://www.globalkeysolutions.net/records/483/aurobindo-pharma-usa-inc/f6ef80a5-e111-473f-8790-4c56e45e472a

> FDA 483 for Aurobindo Pharma USA Inc on May 15, 2024. Product: N/A. Access full analysis and detailed observations.

---

## Details

- Record Type: 483
- Company Name: Aurobindo Pharma USA Inc
- Inspection Date: 2024-05-15

## Related Documents

- [483 - 2024-05-13](https://www.globalkeysolutions.net/records/483/aurobindo-pharma-usa-inc/23d87088-0c57-415a-b47d-edecbaeb8f2b)
- [483 - Unknown Date](https://www.globalkeysolutions.net/records/483/aurobindo-pharma-usa-inc/bcdbf4e9-69c4-4201-abf4-0d0a564f7847)
- [483 - 2024-05-15](https://www.globalkeysolutions.net/records/483/aurobindo-pharma-usa-inc/3b5c88b5-10ab-45e6-8963-dd88eb09d461)
- [483 - Unknown Date](https://www.globalkeysolutions.net/records/483/aurobindo-pharma-usa-inc/bfa24a37-ba1b-4572-90bb-a166c42e6adb)
- [483 - Unknown Date](https://www.globalkeysolutions.net/records/483/aurobindo-pharma-usa-inc/74f2f848-9691-4c89-9129-11c972604f80)

## Related Officers

- [Drug Investigator](https://www.globalkeysolutions.net/people/samir-c-gala/904c34ee-013d-4663-a87a-9cbdbcf2b40e)

Company: https://www.globalkeysolutions.net/companies/aurobindo-pharma-usa-inc/a8dbf5ca-1af1-432a-85b6-5a0c7499eaa5